Skip to content

Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder

Maintenance of Response To Transcranial Magnetic Stimulation (TMS) in Major Depressive Disorder (MDD) Using Monthly TMS Treatment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04076644
Enrollment
11
Registered
2019-09-03
Start date
2019-09-01
Completion date
2021-09-01
Last updated
2023-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MDD

Keywords

TMS

Brief summary

This an open label study using a FDA-cleared TMS stimulation protocols which will be used to treat patients who have responded or remitted from depression using acute clinical TMS therapy at the University of Missouri-Columbia Neuromodulation Clinic. TMS therapy will be given to subjects at monthly intervals. Depression severity questionnaires will be given monthly to determine if the subjects original response to TMS can be maintained. Subjects will be tapered down from antidepressant medication prior to TMS maintenance treatment. Results will be analyzed to determine the effectiveness and feasibility of maintenance TMS therapies in a clinical setting.

Detailed description

This an open label study using Transcranial Magnetic Stimulation (TMS) as a maintenance treatment for subjects that have seen a clinically significant response or remission from their depressive symptoms after having had an acute clinical course of TMS. All potential subjects must have been treated at the University of Missouri Columbia Neuromodulation Clinic to qualify. There are 2 arms in this study. The first is a group of patients who will not receive any TMS treatments and will be followed for a year, and have their depression severity assessed monthly using the Personal Health Questionnaire (PHQ9), and the Quick Inventory of Depressive Symptoms. The second arm will receive TMS treatments 5 times/month for 12 months, be assessed for changes in depressive symptom severity monthly using the PHQ9 and QIDS. TMS treatment protocols will consist of wither the standard 20min 10Hz protocol, or a 3min theta-burst protocol. The protocol used will be determined by what worked for the subject when they were treated clinically at the University of Missouri Columbia Neuromodulation clinic. Subjects in this arm will be tapered of antidepressant medication prior to monthly TMS treatment and will remain antidepressant free for the duration of the study. The study will be a year long in duration.

Interventions

TMS using either a standard 10hz 20min or 3 min theta burst protocol

Sponsors

University of Missouri-Columbia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Must have recently (within 4 weeks) completed an acute TMS course (full 36 treatments) at the University of Missouri Columbia Neuromodulation clinic * Must have clinically responded to the acute TMS treatment course (≥50% improvement according to the clinical depressive scale used - usually the PHQ-9) * Must be able sign consent * Must have a current address and phone number * Must have current mental health care provider, either psychiatrist or general practioner who they see for mental health symptom management * Must be able to taper off antidepressant medication before 1st monthly treatment block (treatment group only)

Exclusion criteria

* \- Subject that has not completed a full acute treatment course, including taper * Subjects that have changed anything that may not make them safe for TMS, which are (all changes will be reviewed by study MD, and will not necessarily be excluded possibly depending on severity): * Any new metal near head * Any new medical devices that cannot be removed * Any new pregnancies (verbally confirmed) * Seizures that occurred post-acute TMS treatment * Any uncontrolled cardiovascular disease * Any new head trauma * Any new illness causing injury to brain * Any new medications which cannot be altered or lowered that may be contraindicated for TMS treatment * Any drug or alcohol use deemed by the study doctor as unsafe for TMS treatment * Subjects unwilling to sign consent or follow study procedures * Subjects with known extended travel plans which may affect study procedures and scheduled TMS treatment

Design outcomes

Primary

MeasureTime frameDescription
Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)given at monthly intervals for 12 monthsThe scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block, scale is 0-27 with 0=no depression, 27=severe depression
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scoresgiven at baseline and before and after TMS treatment block for 12 monthsThe scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block (Pre Trt Month) and after every monthly TMS treatment block (Post Trt Month) ,scale is 0-27 with 0=no depression, 27=severe depression
Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scoresgiven at baseline and before and after each TMS treatment block for 12 monthsThe scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block (Pre Trt Month) and after every monthly TMS treatment block (Post Trt Month) ,scale is 0-27 with 0=no depression, 27=severe depression

Countries

United States

Participant flow

Recruitment details

Dates of recruitment were from 8/14/2019 to 5/21/2021. Participants were recruited from outpatient interventional psychiatry clinic at University of Missouri

Pre-assignment details

Participants had up to 8 weeks to washout of their antidepressant medication, if they could not handle this washout they could not start maintenance treatment. Although two arms were originally planned due to COVID the 2nd arm consisting of group of patients who will not receive any TMS treatments was unable to be recruited.

Participants by arm

ArmCount
TMS Treatment Arm
Subjects will receive either a 20min 10hz TMS treatment, or a 3min theta-burst TMS treatment at certain monthly intervals. The TMS treatment protocol they receive depends on what they received in their acute clinical treatment. Subjects in the arm will be tapered off antidepressant medication before TMS treatment begins. Subjects will be assessed monthly for depression using QIDS and PHQ9. TMS treatment: TMS using either a standard 10hz 20min or 3 min theta burst protocol
10
Total10

Baseline characteristics

CharacteristicTMS Treatment Arm
Age, Continuous51 years
STANDARD_DEVIATION 16.12
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
Race (NIH/OMB)
White
9 Participants
Region of Enrollment
United States
10 participants
Sex: Female, Male
Female
9 Participants
Sex: Female, Male
Male
1 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 10
other
Total, other adverse events
0 / 10
serious
Total, serious adverse events
0 / 10

Outcome results

Primary

Depression Severity Changes Scored From Patient Health Questionnaire (PHQ9)

The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block, scale is 0-27 with 0=no depression, 27=severe depression

Time frame: given at monthly intervals for 12 months

ArmMeasureGroupValue (MEAN)Dispersion
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Baseline (prior to starting treatment)5 score on a scaleStandard Deviation 4.04
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 16.71 score on a scaleStandard Deviation 3.05
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 28.14 score on a scaleStandard Deviation 3.18
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 39.14 score on a scaleStandard Deviation 4.67
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 46.14 score on a scaleStandard Deviation 4.22
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 57.57 score on a scaleStandard Deviation 6.06
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 65.85 score on a scaleStandard Deviation 3.09
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 75.71 score on a scaleStandard Deviation 3.49
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 85.86 score on a scaleStandard Deviation 4.26
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 97.71 score on a scaleStandard Deviation 6.12
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 106.43 score on a scaleStandard Deviation 5.12
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 117.43 score on a scaleStandard Deviation 5.83
TMS Treatment ArmDepression Severity Changes Scored From Patient Health Questionnaire (PHQ9)Month 126.86 score on a scaleStandard Deviation 4.55
Primary

Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly Scores

The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block (Pre Trt Month) and after every monthly TMS treatment block (Post Trt Month) ,scale is 0-27 with 0=no depression, 27=severe depression

Time frame: given at baseline and before and after each TMS treatment block for 12 months

ArmMeasureGroupValue (MEAN)Dispersion
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresBaseline4.14 score on a scaleStandard Deviation 2.36
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 16.29 score on a scaleStandard Deviation 2.6
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 26 score on a scaleStandard Deviation 2.39
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 35.43 score on a scaleStandard Deviation 2.44
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 44.55 score on a scaleStandard Deviation 4.06
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 56.14 score on a scaleStandard Deviation 3.72
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 64.71 score on a scaleStandard Deviation 3.88
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 75 score on a scaleStandard Deviation 2.53
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 85.43 score on a scaleStandard Deviation 3.02
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 96.57 score on a scaleStandard Deviation 4.56
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 105 score on a scaleStandard Deviation 4.14
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 115.57 score on a scaleStandard Deviation 3.42
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Post Treatment Monthly ScoresPost Trt Month 125.43 score on a scaleStandard Deviation 3.29
Primary

Depression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly Scores

The scale was given at the prior to study starting TMS treatments for the study as a baseline measurement. It was then given prior to every monthly TMS treatment block (Pre Trt Month) and after every monthly TMS treatment block (Post Trt Month) ,scale is 0-27 with 0=no depression, 27=severe depression

Time frame: given at baseline and before and after TMS treatment block for 12 months

ArmMeasureGroupValue (MEAN)Dispersion
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresBaseline4.14 score on a scaleStandard Deviation 2.36
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 17.57 score on a scaleStandard Deviation 3.33
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 28.86 score on a scaleStandard Deviation 4.09
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 38.43 score on a scaleStandard Deviation 4.27
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 46.86 score on a scaleStandard Deviation 4.55
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 58.86 score on a scaleStandard Deviation 5.67
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 67 score on a scaleStandard Deviation 6.07
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 75.43 score on a scaleStandard Deviation 2.82
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 86.29 score on a scaleStandard Deviation 3.41
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 98.71 score on a scaleStandard Deviation 5.9
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 106.86 score on a scaleStandard Deviation 5.17
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 117.57 score on a scaleStandard Deviation 4.66
TMS Treatment ArmDepression Severity Changes Scored From Quick Inventory of Depression Symptom Questionnaire (QIDS) Pre Treatment Monthly ScoresPre Trt Month 128.71 score on a scaleStandard Deviation 4.91

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026